{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"AI News Podcast | Latest AI News, Analysis & Events | Daily Inference","title":"🤖 Anthropic Is Making Its Own Drugs — And That's Just the Start","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/4bf6b545\"></iframe>","width":"100%","height":180,"duration":461,"description":"AI just got a lot more complicated. Anthropic is pivoting hard into pharmaceutical development while simultaneously negotiating a custom chip deal with Samsung — signaling a new era of vertical integration that goes far beyond chatbots. OpenAI's Sam Altman is reportedly pushing to hand five percent of the company's equity to a US sovereign wealth fund, raising urgent questions about who really benefits from the AI wealth explosion. In the UK, authorities are sounding the alarm for parents everywhere, warning that AI-powered 'nudification' apps are being used to exploit children's publicly posted photos in deeply disturbing ways. The question of whether human or AI-generated writing can even be told apart is no longer theoretical — it's now landing in courtrooms, newsrooms, and literary circles. Meanwhile, at Google DeepMind, employees trying to unionize are hitting walls, and a broader philosophical debate is gaining traction: has AI's ethical direction already been quietly decided by financial incentives, long before the rest of us got a vote?\nSubscribe to Daily Inference: dailyinference.com\nLove AI? Check out our other AI tools: 60sec.site and Artificial Intelligence Radio","thumbnail_url":"https://img.transistorcdn.com/oALmYlw2Ib4sXs8cHlaPQbASHxs4K6B-zBLmQ6_bsDQ/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9iZTc2/YWQ4Nzc4MzExODRk/ZjBiM2NmZjkxOWVm/MWQ3My5wbmc.webp","thumbnail_width":300,"thumbnail_height":300}